Marina Lanciotti

1.3k total citations
51 papers, 733 citations indexed

About

Marina Lanciotti is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Marina Lanciotti has authored 51 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 18 papers in Genetics and 18 papers in Immunology. Recurrent topics in Marina Lanciotti's work include Blood disorders and treatments (14 papers), Immunodeficiency and Autoimmune Disorders (11 papers) and Acute Lymphoblastic Leukemia research (8 papers). Marina Lanciotti is often cited by papers focused on Blood disorders and treatments (14 papers), Immunodeficiency and Autoimmune Disorders (11 papers) and Acute Lymphoblastic Leukemia research (8 papers). Marina Lanciotti collaborates with scholars based in Italy, Japan and United States. Marina Lanciotti's co-authors include Mirco Ponzoni, P. Cornaglia‐Ferraris, Carlo Dufour, P. G. Montaldo, Giovanni Candiano, Marta Pillon, Ugo Ramenghi, Riccardo Haupt, Johanna Svahn and Daniela Di Martino and has published in prestigious journals such as Blood, Biochemistry and Analytical Biochemistry.

In The Last Decade

Marina Lanciotti

49 papers receiving 707 citations

Peers

Countries citing papers authored by Marina Lanciotti

Since Specialization

Citations

This map shows the geographic impact of Marina Lanciotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Lanciotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Lanciotti more than expected).

Fields of papers citing papers by Marina Lanciotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Lanciotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Lanciotti. The network helps show where Marina Lanciotti may publish in the future.

Co-authorship network of co-authors of Marina Lanciotti

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Lanciotti. A scholar is included among the top collaborators of Marina Lanciotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Lanciotti. Marina Lanciotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sodium-Glucose Transporter-2 Inhibitors (SGLT2i) and Myocardial Ischemia: Another Compelling Reason to Consider These Agents Regardless of Diabetes 2025 ·International Journal of Molecular Sciences ·(unknown), Marina Lanciotti, Annunziata Nusca, (unknown), (unknown), (unknown), Gian Paolo Ussia, Francesco Grigioni	4
2	12 Infection risk in a cohort of patients with Autoimmune Cytopenias and Primary Immuno-Regulatory Disorders treated with mycophenolate mofetil and sirolimus 2024 ·Clinical Immunology ·Maurizio Miano, (unknown), Elena Palmisani, Marcello Mariani, (unknown), (unknown), (unknown), (unknown), Alice Grossi, Marina Lanciotti, Maria Licciardello, (unknown), Giovanna Russo, Carlo Dufour, Elio Castagnola, Francesca Fioredda	0
3	Infection risk in patients with autoimmune cytopenias and immune dysregulation treated with mycophenolate mofetil and sirolimus 2024 ·Frontiers in Immunology ·(unknown), Elena Palmisani, Marcello Mariani, (unknown), Maria Licciardello, (unknown), (unknown), (unknown), Alice Grossi, Marina Lanciotti, (unknown), (unknown), Giovanna Russo, Carlo Dufour, Francesca Fioredda, Elio Castagnola, Maurizio Miano	0
4	Mutational analysis of ribosomal proteins in a cohort of pediatric patients with T-cell acute lymphoblastic leukemia reveals Q123R, a novel mutation in RPL10 2022 ·Frontiers in Genetics ·(unknown), Valentina Indio, (unknown), Cristina Bugarin, (unknown), Alberto Del Río, Daniela Pollutri, Fraia Melchionda, Andrea Pession, Marina Lanciotti, Carlo Dufour, Giuseppe Gaipa, Lorenzo Montanaro, Marianna Penzo	2
5	Targeted NGS Yields Plentiful Ultra-Rare Variants in Inborn Errors of Immunity Patients 2021 ·Genes ·Alice Grossi, Maurizio Miano, Marina Lanciotti, Francesca Fioredda, (unknown), Elena Palmisani, Paola Terranova, Giuseppe Santamaria, Francesco Caroli, Roberta Caorsi, Stefano Volpi, Marco Gattorno, Carlo Dufour, Isabella Ceccherini	7
6	Genetic screening of children with marrow failure. The role of primary Immunodeficiencies 2021 ·American Journal of Hematology ·Maurizio Miano, Alice Grossi, (unknown), Marina Lanciotti, Francesca Fioredda, Elena Palmisani, Tiziana Lanza, (unknown), (unknown), Silvia Ravera, Vanessa Cossu, Paola Terranova, Fiorina Giona, Michelina Santopietro, Enrico Cappelli, Isabella Ceccherini, Carlo Dufour	10
7	Clinical Heterogeneity in a Family with DKC1 Mutation, Dyskeratosis Congenita and Hoyeraal-Hreidarsson Syndrome in First Cousins 2017 ·Pediatric Reports ·(unknown), Anna Mondino, Matteo Chinello, Alessandra Risso, (unknown), Marina Lanciotti, Andrea Guala	7
8	Poikiloderma With Neutropenia 2013 ·Journal of Pediatric Hematology/Oncology ·Piero Farruggia, Stefania Indaco, Carlo Dufour, Tiziana Lanza, (unknown), (unknown), (unknown), Paolo D’Angelo, Marina Lanciotti	11
9	Congenital and acquired neutropenia consensus guidelines on diagnosis from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato‐Oncologia Pediatrica) 2011 ·Pediatric Blood & Cancer ·Francesca Fioredda, Michaela Calvillo, Sonia Bonanomi, Tiziana Coliva, Fábio C. Tucci, Piero Farruggia, Marta Pillon, Baldassarre Martire, Roberta Ghilardi, Ugo Ramenghi, (unknown), Giuseppe Menna, Angelica Barone, Marina Lanciotti, Carlo Dufour	38
10	Digenic mutations in severe congenital neutropenia 2010 ·Haematologica ·Manuela Germeshausen, Cornelia Zeidler, Manfred Stuhrmann, Marina Lanciotti, Matthias Ballmaier, Karl Welte	41
11	Changes in cytokine profile pre- and post-immunosuppression in acquired aplastic anemia 2009 ·Haematologica ·Carlo Dufour, Elisa Ferretti, Francesca Bagnasco, (unknown), Marina Lanciotti, Ugo Ramenghi, Paola Saracco, M. T. Van Lint, Daniela Longoni, G Torelli, Marta Pillon, Anna Locasciulli, (unknown), (unknown), Andrea Bacigalupo, Vito Pistoia, Anna Corcione, Johanna Svahn, (unknown)	23
12	Human Fanconi A cells are susceptible to TRAIL‐induced apoptosis 2006 ·British Journal of Haematology ·(unknown), Elisa Ferretti, Marina Lanciotti, Maurizio Bruschi, Giovanni Candiano, Johanna Svahn, Laura S. Haneline, Carlo Dufour, Vito Pistoia, Anna Corcione	9
13	Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements 2004 ·Leukemia ·Marina Lanciotti, Carlo Dufour, Lilia Corral, Michele Pilato, (unknown), Giulio Rossi, Giuseppe Basso, Anna Leszl, Matteo Luciani, Luca Lo Nigro, Concetta Micalizzi, Maria Grazia Valsecchi, Andrea Biondi, Riccardo Haupt	37
14	Association of cytogenetic abnormalities with detection of BCR‐ABL fusion transcripts in children with T‐lineage lymphoproliferative diseases (T‐ALL and T‐NHL) 2003 ·Pediatric Blood & Cancer ·Luca Lo Nigro, Laura Sainati, (unknown), Marina Lanciotti, (unknown), Anna Leszl, Giuseppe Basso	9
15	Detection of T cell receptor delta gene rearrangements in childhood B and T lineage acute lymphoblastic leukaemia by southern blot and PCR: technical comparison of two methods of analysis 2000 ·Clinical & Laboratory Haematology ·Angelo Valetto, Daniela Di Martino, Francesca Scuderi, Tiziana Lanza, Marina Lanciotti, (unknown), Giorgio Dini	2
16	Rapid detection of γT cell receptor gene rearrangements in acute lymphoblastic leukemia by electrophoresis and silver staining: Implications for detection of minimal residual disease 1998 ·Electrophoresis ·Angelo Valetto, Marina Lanciotti, Daniela Di Martino, (unknown), (unknown), (unknown), Giovanni Candiano	2
17	A combined evaluation of biochemical and morphological changes during human neuroblastoma cell differentiation 1992 ·Cellular and Molecular Neurobiology ·Marina Lanciotti, P. G. Montaldo, (unknown), Enrico Lucarelli, P. Cornaglia‐Ferraris, Mirco Ponzoni	21
18	Retinoic acid inhibits phosphatidylinositol turnover only in RA-sensitive while not in RA-resistant human neuroblastoma cells 1989 ·Biochemical and Biophysical Research Communications ·Marina Lanciotti, Patrizia Longone, P. Cornaglia‐Ferraris, Mirco Ponzoni	9
19	Morphologic and phenotypic changes of human neuroblastoma cells in culture induced by cytosine arabinoside 1989 ·Experimental Cell Research ·Mirco Ponzoni, Marina Lanciotti, (unknown), (unknown), P. Cornaglia‐Ferraris	16
20	Purification to homogeneity and biochemical characterization of two suppressor factors from human malignant T-cells 1988 ·Biochemical and Biophysical Research Communications ·Mirco Ponzoni, P. G. Montaldo, Marina Lanciotti, Elio Castagnola, (unknown), P. Cornaglia‐Ferraris	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact